Skip to main content

Table 3 The BDNF level for MS patients in remission, MS patients in relapse, and control groups

From: Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: a potential biomarker for disease activity

 

MS cases in remission (n = 30)

MS cases in relapse (n = 30)

Control (n = 30)

P value

 

Median

Q1

Q3

Median

Q1

Q3

Median

Q1

Q3

 

BDNF (pg/ml)

225

200

325

310

250

950

248

220

325

0.006*

  1. BDNF brain-derived neurotrophic factor
  2. *P value < 0.05 (significant)